Xenon Pharmaceuticals (XENE) Q1 2026 Earnings
XENE·Reported May 7, 2026·After market close
Diluted EPS came in at $-1.17 (-41.0% YoY).
Diluted EPS
$-1.17met estimate
Consensus: $-1.17
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Xenon Pharmaceuticals's Q1 2026 earnings report.
Xenon Pharmaceuticals (XENE) reported Q1 2026 earnings on May 7, 2026 after market close.
Xenon Pharmaceuticals reported diluted EPS of $-1.17 for Q1 2026.
EPS beat the consensus estimate of $-1.17 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 41.0% from $-0.83.
You can read the 8-K earnings release (0001193125-26-211843) and the 10-Q periodic report (0001193125-26-212153) directly on SEC EDGAR. The filing index links above go to sec.gov.